Tower Research Capital LLC (Trc) Vertex Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,164 shares of VRTX stock, worth $2.93 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,164
Previous 36,303 80.27%
Holding current value
$2.93 Million
Previous $17 Million 80.42%
% of portfolio
0.09%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $13.4 Million - $14.7 Million
-29,139 Reduced 80.27%
7,164 $3.33 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $7.28 Million - $9 Million
18,530 Added 104.26%
36,303 $17 Million
Q1 2024

May 15, 2024
SELL
$407.69 - $446.08 $11.3 Million - $12.4 Million
-27,808 Reduced 61.01%
17,773 $7.43 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $10.4 Million - $12.4 Million
30,175 Added 195.87%
45,581 $18.5 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $1.94 Million - $2.08 Million
5,727 Added 59.17%
15,406 $5.36 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $891,380 - $997,664
2,835 Added 41.42%
9,679 $3.41 Million
Q1 2023

May 09, 2023
SELL
$283.23 - $323.1 $772,934 - $881,739
-2,729 Reduced 28.51%
6,844 $2.16 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $14.6 Million - $16.5 Million
-51,240 Reduced 84.26%
9,573 $2.77 Million
Q3 2022

Nov 10, 2022
BUY
$273.83 - $305.53 $3.82 Million - $4.26 Million
13,952 Added 29.77%
60,813 $17.6 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $7.2 Million - $8.96 Million
-30,636 Reduced 39.53%
46,861 $13.2 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $10.6 Million - $12.5 Million
47,754 Added 160.56%
77,497 $20.2 Million
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $685,382 - $865,198
3,872 Added 14.97%
29,743 $6.53 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $2.97 Million - $3.32 Million
16,368 Added 172.24%
25,871 $4.69 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $4.11 Million - $4.85 Million
-21,931 Reduced 69.77%
9,503 $1.92 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $5.13 Million - $5.98 Million
24,782 Added 372.55%
31,434 $6.76 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $1.52 Million - $2.03 Million
-7,344 Reduced 52.47%
6,652 $1.57 Million
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $2.14 Million - $2.54 Million
8,388 Added 149.57%
13,996 $3.81 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $1.24 Million - $1.63 Million
5,495 Added 4862.83%
5,608 $1.63 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $156,619 - $194,283
-784 Reduced 87.4%
113 $27,000
Q4 2019

Feb 07, 2020
SELL
$166.71 - $223.91 $789,538 - $1.06 Million
-4,736 Reduced 84.08%
897 $196,000
Q3 2019

Nov 05, 2019
BUY
$166.23 - $187.09 $936,373 - $1.05 Million
5,633 New
5,633 $955,000
Q2 2019

Aug 13, 2019
SELL
$164.61 - $190.37 $1.03 Million - $1.19 Million
-6,247 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$163.73 - $194.7 $871,371 - $1.04 Million
5,322 Added 575.35%
6,247 $1.15 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $120,008 - $151,845
-790 Reduced 46.06%
925 $153,000
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $1.83 Million - $2.1 Million
-10,919 Reduced 86.43%
1,715 $331,000
Q2 2018

Aug 15, 2018
BUY
$145.72 - $169.96 $1.82 Million - $2.12 Million
12,468 Added 7510.84%
12,634 $2.15 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $56,243 - $65,715
-371 Reduced 69.09%
166 $27,000
Q4 2017

Feb 09, 2018
SELL
$137.28 - $155.55 $254,242 - $288,078
-1,852 Reduced 77.52%
537 $81,000
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $353,882 - $387,591
2,389
2,389 $363,000

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email